Annual EBITDA
-$14.13 M
-$939.00 K-7.12%
31 December 2023
Summary:
Yield10 Bioscience annual earnings before interest, taxes, depreciation & amortization is currently -$14.13 million, with the most recent change of -$939.00 thousand (-7.12%) on 31 December 2023. During the last 3 years, it has fallen by -$4.70 million (-49.86%). YTEN annual EBITDA is now -370.27% below its all-time high of $5.23 million, reached on 31 December 2012.YTEN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.14 M
-$769.00 K-32.39%
30 June 2024
Summary:
Yield10 Bioscience quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.14 million, with the most recent change of -$769.00 thousand (-32.39%) on 30 June 2024. Over the past year, it has increased by +$488.00 thousand (+13.44%). YTEN quarterly EBITDA is now -110.76% below its all-time high of $29.20 million, reached on 31 March 2012.YTEN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$12.32 M
+$448.00 K+3.51%
30 June 2024
Summary:
Yield10 Bioscience TTM earnings before interest, taxes, depreciation & amortization is currently -$12.32 million, with the most recent change of +$448.00 thousand (+3.51%) on 30 June 2024. Over the past year, it has increased by +$1.77 million (+12.55%). YTEN TTM EBITDA is now -335.74% below its all-time high of $5.23 million, reached on 31 December 2012.YTEN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | +13.4% | +12.6% |
| 3 y3 years | -49.9% | -3.6% | -10.8% |
| 5 y5 years | -54.9% | -61.3% | -56.5% |
YTEN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -49.9% | at low | -32.4% | +15.8% | -10.8% | +12.8% |
| 5 y | 5 years | -68.3% | at low | -61.3% | +15.8% | -56.5% | +12.8% |
| alltime | all time | -370.3% | +62.2% | -110.8% | +67.4% | -335.7% | +67.2% |
Yield10 Bioscience EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$3.14 M(+32.4%) | -$12.32 M(-3.5%) |
| Mar 2024 | - | -$2.37 M(-25.2%) | -$12.77 M(-9.6%) |
| Dec 2023 | -$14.13 M(+7.1%) | -$3.17 M(-12.6%) | -$14.13 M(+0.3%) |
| Sept 2023 | - | -$3.63 M(+1.1%) | -$14.09 M(+1.5%) |
| June 2023 | - | -$3.59 M(-3.8%) | -$13.88 M(+1.6%) |
| Mar 2023 | - | -$3.73 M(+18.9%) | -$13.66 M(+3.6%) |
| Dec 2022 | -$13.19 M(+15.0%) | -$3.14 M(-8.3%) | -$13.19 M(+1.7%) |
| Sept 2022 | - | -$3.42 M(+1.6%) | -$12.96 M(+3.1%) |
| June 2022 | - | -$3.37 M(+3.2%) | -$12.58 M(+2.8%) |
| Mar 2022 | - | -$3.26 M(+12.0%) | -$12.24 M(+6.7%) |
| Dec 2021 | -$11.47 M(+21.7%) | -$2.91 M(-4.0%) | -$11.47 M(+3.1%) |
| Sept 2021 | - | -$3.03 M(+0.2%) | -$11.12 M(+8.7%) |
| June 2021 | - | -$3.03 M(+21.2%) | -$10.24 M(+10.0%) |
| Mar 2021 | - | -$2.50 M(-2.6%) | -$9.30 M(-1.3%) |
| Dec 2020 | -$9.43 M(+12.3%) | -$2.56 M(+19.4%) | -$9.43 M(+2.2%) |
| Sept 2020 | - | -$2.15 M(+2.6%) | -$9.22 M(+2.2%) |
| June 2020 | - | -$2.09 M(-20.1%) | -$9.02 M(+2.8%) |
| Mar 2020 | - | -$2.62 M(+10.9%) | -$8.78 M(+4.6%) |
| Dec 2019 | -$8.39 M(-8.0%) | -$2.36 M(+21.3%) | -$8.39 M(+6.6%) |
| Sept 2019 | - | -$1.95 M(+5.4%) | -$7.88 M(-7.9%) |
| June 2019 | - | -$1.85 M(-17.3%) | -$8.55 M(-5.9%) |
| Mar 2019 | - | -$2.23 M(+21.1%) | -$9.09 M(-0.4%) |
| Dec 2018 | -$9.12 M(+0.5%) | -$1.84 M(-29.7%) | -$9.12 M(-6.5%) |
| Sept 2018 | - | -$2.63 M(+10.2%) | -$9.76 M(+7.7%) |
| June 2018 | - | -$2.38 M(+4.9%) | -$9.06 M(-3.0%) |
| Mar 2018 | - | -$2.27 M(-8.5%) | -$9.34 M(+2.9%) |
| Dec 2017 | -$9.08 M(-6.7%) | -$2.48 M(+28.5%) | -$9.08 M(+11.6%) |
| Sept 2017 | - | -$1.93 M(-27.4%) | -$8.13 M(-5.7%) |
| June 2017 | - | -$2.66 M(+32.4%) | -$8.62 M(+3.6%) |
| Mar 2017 | - | -$2.01 M(+30.7%) | -$8.32 M(-14.5%) |
| Dec 2016 | -$9.73 M(-20.2%) | -$1.54 M(-36.5%) | -$9.73 M(-13.1%) |
| Sept 2016 | - | -$2.42 M(+2.5%) | -$11.20 M(-5.3%) |
| June 2016 | - | -$2.36 M(-31.1%) | -$11.82 M(-24.0%) |
| Mar 2016 | - | -$3.42 M(+13.9%) | -$15.55 M(-13.1%) |
| Dec 2015 | -$12.20 M(-53.6%) | -$3.00 M(-1.2%) | -$17.90 M(-13.4%) |
| Sept 2015 | - | -$3.04 M(-50.0%) | -$20.67 M(-14.8%) |
| June 2015 | - | -$6.08 M(+5.4%) | -$24.25 M(-2.2%) |
| Mar 2015 | - | -$5.78 M(0.0%) | -$24.79 M(-5.8%) |
| Dec 2014 | -$26.32 M(-4.7%) | -$5.78 M(-12.7%) | -$26.32 M(-7.8%) |
| Sept 2014 | - | -$6.62 M(-0.1%) | -$28.54 M(+1.2%) |
| June 2014 | - | -$6.62 M(-9.3%) | -$28.21 M(-3.4%) |
| Mar 2014 | - | -$7.31 M(-8.6%) | -$29.20 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$27.61 M(-628.3%) | -$7.99 M(+27.2%) | -$28.39 M(-3.2%) |
| Sept 2013 | - | -$6.28 M(-17.6%) | -$29.32 M(-3.8%) |
| June 2013 | - | -$7.62 M(+17.4%) | -$30.47 M(+0.0%) |
| Mar 2013 | - | -$6.49 M(-27.3%) | -$30.46 M(-682.8%) |
| Dec 2012 | $5.23 M(-114.0%) | -$8.92 M(+20.0%) | $5.23 M(+6.6%) |
| Sept 2012 | - | -$7.43 M(-2.4%) | $4.91 M(+57.0%) |
| June 2012 | - | -$7.62 M(-126.1%) | $3.13 M(+178.0%) |
| Mar 2012 | - | $29.20 M(-415.9%) | $1.12 M(-103.0%) |
| Dec 2011 | -$37.35 M(+0.2%) | -$9.24 M(+0.3%) | -$37.35 M(+0.5%) |
| Sept 2011 | - | -$9.21 M(-4.2%) | -$37.15 M(-1.1%) |
| June 2011 | - | -$9.62 M(+3.7%) | -$37.57 M(+1.1%) |
| Mar 2011 | - | -$9.28 M(+2.6%) | -$37.15 M(-0.4%) |
| Dec 2010 | -$37.29 M(+3.6%) | -$9.04 M(-6.1%) | -$37.29 M(-0.2%) |
| Sept 2010 | - | -$9.63 M(+4.7%) | -$37.36 M(+2.2%) |
| June 2010 | - | -$9.20 M(-2.4%) | -$36.55 M(-0.1%) |
| Mar 2010 | - | -$9.42 M(+3.4%) | -$36.59 M(+1.6%) |
| Dec 2009 | -$35.99 M(+2.4%) | -$9.11 M(+3.3%) | -$35.99 M(+2.1%) |
| Sept 2009 | - | -$8.82 M(-4.5%) | -$35.26 M(-1.4%) |
| June 2009 | - | -$9.23 M(+4.5%) | -$35.76 M(+1.4%) |
| Mar 2009 | - | -$8.83 M(+5.5%) | -$35.26 M(+0.3%) |
| Dec 2008 | -$35.16 M(+8.6%) | -$8.38 M(-10.1%) | -$35.16 M(+1.1%) |
| Sept 2008 | - | -$9.32 M(+6.6%) | -$34.77 M(-0.5%) |
| June 2008 | - | -$8.74 M(+0.1%) | -$34.93 M(-0.5%) |
| Mar 2008 | - | -$8.73 M(+9.3%) | -$35.12 M(+8.5%) |
| Dec 2007 | -$32.37 M(+95.4%) | -$7.99 M(-15.8%) | -$32.36 M(-0.4%) |
| Sept 2007 | - | -$9.48 M(+6.3%) | -$32.51 M(+19.5%) |
| June 2007 | - | -$8.92 M(+49.2%) | -$27.21 M(+22.2%) |
| Mar 2007 | - | -$5.98 M(-26.4%) | -$22.27 M(+34.5%) |
| Dec 2006 | -$16.56 M(+146.8%) | -$8.13 M(+94.2%) | -$16.56 M(-5.9%) |
| Sept 2006 | - | -$4.18 M(+5.2%) | -$17.60 M(+37.7%) |
| June 2006 | - | -$3.98 M(+1390.6%) | -$12.78 M(+59.9%) |
| Mar 2006 | - | -$267.00 K(-97.1%) | -$7.99 M(+13.8%) |
| Dec 2005 | -$6.71 M(+41.7%) | -$9.17 M(-1541.6%) | -$7.02 M(+25.1%) |
| Sept 2005 | - | $636.10 K(-21.2%) | -$5.61 M(+5.3%) |
| June 2005 | - | $807.50 K(+15.1%) | -$5.33 M(+2.1%) |
| Mar 2005 | - | $701.40 K(-109.0%) | -$5.22 M(+4.4%) |
| Dec 2004 | -$4.73 M(-298.7%) | -$7.76 M(-943.7%) | -$5.00 M(-281.2%) |
| Sept 2004 | - | $919.60 K(0.0%) | $2.76 M(+50.0%) |
| June 2004 | - | $919.60 K(0.0%) | $1.84 M(+100.0%) |
| Mar 2004 | - | $919.60 K | $919.60 K |
| Dec 2003 | $2.38 M(-147.1%) | - | - |
| Dec 2002 | -$5.06 M | - | - |
FAQ
- What is Yield10 Bioscience annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Yield10 Bioscience?
- What is Yield10 Bioscience annual EBITDA year-on-year change?
- What is Yield10 Bioscience quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly EBITDA year-on-year change?
- What is Yield10 Bioscience TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Yield10 Bioscience?
- What is Yield10 Bioscience TTM EBITDA year-on-year change?
What is Yield10 Bioscience annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of YTEN is -$14.13 M
What is the all time high annual EBITDA for Yield10 Bioscience?
Yield10 Bioscience all-time high annual earnings before interest, taxes, depreciation & amortization is $5.23 M
What is Yield10 Bioscience annual EBITDA year-on-year change?
Over the past year, YTEN annual earnings before interest, taxes, depreciation & amortization has changed by -$939.00 K (-7.12%)
What is Yield10 Bioscience quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of YTEN is -$3.14 M
What is the all time high quarterly EBITDA for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly earnings before interest, taxes, depreciation & amortization is $29.20 M
What is Yield10 Bioscience quarterly EBITDA year-on-year change?
Over the past year, YTEN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$488.00 K (+13.44%)
What is Yield10 Bioscience TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of YTEN is -$12.32 M
What is the all time high TTM EBITDA for Yield10 Bioscience?
Yield10 Bioscience all-time high TTM earnings before interest, taxes, depreciation & amortization is $5.23 M
What is Yield10 Bioscience TTM EBITDA year-on-year change?
Over the past year, YTEN TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.77 M (+12.55%)